Finance

Beta
Lists
CYRX:NASDAQ
CryoPort Inc
$16.00
+0.76%
(+0.12) 1D
$16.02
+0.13% (+0.020)
Pre-market
Closed: Jun 26, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CYRX...
Open
$15.71
High
$16.08
Low
$15.53
Mkt. cap
806.44M
Avg. vol.
891.91K
Volume
0.00
P/E ratio
11.85
52-wk high
$16.73
52-wk low
$6.69
EPS
$1.35
Beta
1.90
Shares outstanding
50.40M
No. of employees
688
Open
$15.71
High
$16.08
Low
$15.53
Mkt. cap
806.44M
Avg. vol.
891.91K
Volume
0.00
P/E ratio
11.85
52-wk high
$16.73
52-wk low
$6.69
EPS
$1.35
Beta
1.90
Shares outstanding
50.40M
No. of employees
688
News stories
From sources across the web
About CryoPort Inc
CEO-
Employees688
Founded1990
HeadquartersBrentwood, Tennessee, United States
SectorHealth care
Websitecryoportinc.com
Analyst ratings
Based on 7 analysts giving stock ratings to CYRX in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CYRX in the last 3 months.
Highest
Current $16.00
$17.00 (+6.25%)
Average
$14.83 (-7.31%)
Lowest
$12.00 (-25.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matt Hewitt
Craig-Hallum
Buy
Maintained
-
-
06/24/2026
Matthew Stanton, CFA
Jefferies
Hold
Maintained
$13.00
-18.8%
06/08/2026
Paul Knight
KeyBanc
Buy
Maintained
$17.00
+6.2%
05/20/2026
Richard Baldry
Roth MKM
Buy
Maintained
$15.00
-6.2%
05/05/2026
David Larsen
BTIG
Buy
Maintained
$17.00
+6.2%
05/05/2026
Subbu Nambi
Guggenheim
Buy
Maintained
$12.00
-25%
05/05/2026
David Saxon
Needham
Buy
Reiterated
$15.00
-6.2%
05/05/2026
Greg Palm
Craig-Hallum
Buy
Maintained
-
-
04/17/2026
George Sutton
Craig-Hallum
Buy
Initiated
-
-
04/07/2026
Unknown Analyst
Jefferies
Hold
Reiterated
$9.50
-40.6%
04/01/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$11.00
-31.2%
03/03/2026
Unknown Analyst
Stephens
Buy
Maintained
$13.00
-18.8%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
45.45M
44.23M
45.45M
47.80M
Cost of goods sold
24.08M
22.91M
23.74M
25.88M
Cost of revenue
24.08M
22.91M
23.74M
25.88M
Research and development expenses
4.12M
4.52M
4.47M
3.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.10M
26.54M
17.63M
27.60M
Operating expense
28.22M
31.06M
22.10M
31.51M
Total operating expenses
52.30M
53.97M
45.84M
57.40M
Operating income
-6.85M
-9.73M
-386.00K
-9.60M
Other non operating income
145.00K
144.00K
-926.00K
191.00K
EBT including unusual items
-9.45M
-6.53M
-7.40M
-9.32M
EBT excluding unusual items
-7.86M
-6.99M
2.33M
-7.20M
Income tax expense
274.00K
165.00K
1.13M
108.00K
Effective tax rate
-2.90%
-2.53%
-15.23%
-1.16%
Other operating expenses
-
-
-
-
Net income
108.87M
-6.94M
-11.64M
-10.54M
Net profit margin
239.51%
-15.70%
-25.62%
-22.06%
Earnings per share
-0.24
-0.13
-0.17
-0.19
Interest and investment income
1.47M
3.40M
3.36M
3.09M
Interest expense
-618.00K
-526.00K
-634.00K
-432.00K
Net interest expenses
848.00K
2.88M
2.72M
2.66M
Depreciation and amortization charges
-
-
-
-
EBITDA
450.00K
-5.88M
8.53M
-3.20M
Gain or loss from assets sale
-116.56M
-
3.96M
30.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of CYRX
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer